Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy

Abstract Background Non-adherence has been associated with reduced graft survival. The aim of this study was to investigate the immunological mechanisms underlying chronic renal allograft rejection using a model of non-adherence to immunosuppressive therapy. We used a MHC (major histocompatibility c...

Full description

Bibliographic Details
Main Authors: Louisa Kühne, Bettina Jung, Helen Poth, Antonia Schuster, Simone Wurm, Petra Ruemmele, Bernhard Banas, Tobias Bergler
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Immunology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12865-017-0236-6
_version_ 1828793188976951296
author Louisa Kühne
Bettina Jung
Helen Poth
Antonia Schuster
Simone Wurm
Petra Ruemmele
Bernhard Banas
Tobias Bergler
author_facet Louisa Kühne
Bettina Jung
Helen Poth
Antonia Schuster
Simone Wurm
Petra Ruemmele
Bernhard Banas
Tobias Bergler
author_sort Louisa Kühne
collection DOAJ
description Abstract Background Non-adherence has been associated with reduced graft survival. The aim of this study was to investigate the immunological mechanisms underlying chronic renal allograft rejection using a model of non-adherence to immunosuppressive therapy. We used a MHC (major histocompatibility complex) -mismatched rat model of renal transplantation (Brown Norway to Lewis), in which rats received daily oral cyclosporine A. In analogy to non-adherence to therapy, one group received cyclosporine A on alternating days only. Rejection was histologically graded according to the Banff classification. We quantified fibrosis by trichrome staining and intra-graft infiltration of T cells, B cells, and monocytes/macrophages by immunohistochemistry. The distribution of B lymphocytes was assessed using immunofluorescence microscopy. Intra-graft chemokine, chemokine receptor, BAFF (B cell activating factor belonging to the TNF family), and immunoglobulin G transcription levels were analysed by RT-PCR. Finally, we evaluated donor-specific antibodies (DSA) and complement-dependent cytotoxicity using flow cytometry. Results After 28 days, cellular rejection occurred during non-adherence in 5/6 animals, mixed with humoral rejection in 3/6 animals. After non-adherence, the number of T lymphocytes were elevated compared to daily immunosuppression. Monocyte numbers declined over time. Accordingly, lymphocyte chemokine transcription was significantly increased in the graft, as was the transcription of BAFF, BAFF receptor, and Immunoglobulin G. Donor specific antibodies were elevated in non-adherence, but did not induce complement-dependent cytotoxicity. Conclusion Cellular and humoral rejection, lymphocyte infiltration, and de novo DSA are induced in this model of non-adherence.
first_indexed 2024-12-12T03:23:02Z
format Article
id doaj.art-aa5e1048859641d39a46708aa7409694
institution Directory Open Access Journal
issn 1471-2172
language English
last_indexed 2024-12-12T03:23:02Z
publishDate 2017-12-01
publisher BMC
record_format Article
series BMC Immunology
spelling doaj.art-aa5e1048859641d39a46708aa74096942022-12-22T00:40:08ZengBMCBMC Immunology1471-21722017-12-0118111410.1186/s12865-017-0236-6Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapyLouisa Kühne0Bettina Jung1Helen Poth2Antonia Schuster3Simone Wurm4Petra Ruemmele5Bernhard Banas6Tobias Bergler7Department of Nephrology, University Hospital RegensburgDepartment of Nephrology, University Hospital RegensburgDepartment of Nephrology, University Hospital RegensburgDepartment of Nephrology, University Hospital RegensburgDepartment of Nephrology, University Hospital RegensburgDepartment of Pathology, University Hospital ErlangenDepartment of Nephrology, University Hospital RegensburgDepartment of Nephrology, University Hospital RegensburgAbstract Background Non-adherence has been associated with reduced graft survival. The aim of this study was to investigate the immunological mechanisms underlying chronic renal allograft rejection using a model of non-adherence to immunosuppressive therapy. We used a MHC (major histocompatibility complex) -mismatched rat model of renal transplantation (Brown Norway to Lewis), in which rats received daily oral cyclosporine A. In analogy to non-adherence to therapy, one group received cyclosporine A on alternating days only. Rejection was histologically graded according to the Banff classification. We quantified fibrosis by trichrome staining and intra-graft infiltration of T cells, B cells, and monocytes/macrophages by immunohistochemistry. The distribution of B lymphocytes was assessed using immunofluorescence microscopy. Intra-graft chemokine, chemokine receptor, BAFF (B cell activating factor belonging to the TNF family), and immunoglobulin G transcription levels were analysed by RT-PCR. Finally, we evaluated donor-specific antibodies (DSA) and complement-dependent cytotoxicity using flow cytometry. Results After 28 days, cellular rejection occurred during non-adherence in 5/6 animals, mixed with humoral rejection in 3/6 animals. After non-adherence, the number of T lymphocytes were elevated compared to daily immunosuppression. Monocyte numbers declined over time. Accordingly, lymphocyte chemokine transcription was significantly increased in the graft, as was the transcription of BAFF, BAFF receptor, and Immunoglobulin G. Donor specific antibodies were elevated in non-adherence, but did not induce complement-dependent cytotoxicity. Conclusion Cellular and humoral rejection, lymphocyte infiltration, and de novo DSA are induced in this model of non-adherence.http://link.springer.com/article/10.1186/s12865-017-0236-6Donor specific antibodiesHumoral rejectionRenal transplantationNon-adherenceLeukocyte infiltrationBAFF
spellingShingle Louisa Kühne
Bettina Jung
Helen Poth
Antonia Schuster
Simone Wurm
Petra Ruemmele
Bernhard Banas
Tobias Bergler
Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
BMC Immunology
Donor specific antibodies
Humoral rejection
Renal transplantation
Non-adherence
Leukocyte infiltration
BAFF
title Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
title_full Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
title_fullStr Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
title_full_unstemmed Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
title_short Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
title_sort renal allograft rejection lymphocyte infiltration and de novo donor specific antibodies in a novel model of non adherence to immunosuppressive therapy
topic Donor specific antibodies
Humoral rejection
Renal transplantation
Non-adherence
Leukocyte infiltration
BAFF
url http://link.springer.com/article/10.1186/s12865-017-0236-6
work_keys_str_mv AT louisakuhne renalallograftrejectionlymphocyteinfiltrationanddenovodonorspecificantibodiesinanovelmodelofnonadherencetoimmunosuppressivetherapy
AT bettinajung renalallograftrejectionlymphocyteinfiltrationanddenovodonorspecificantibodiesinanovelmodelofnonadherencetoimmunosuppressivetherapy
AT helenpoth renalallograftrejectionlymphocyteinfiltrationanddenovodonorspecificantibodiesinanovelmodelofnonadherencetoimmunosuppressivetherapy
AT antoniaschuster renalallograftrejectionlymphocyteinfiltrationanddenovodonorspecificantibodiesinanovelmodelofnonadherencetoimmunosuppressivetherapy
AT simonewurm renalallograftrejectionlymphocyteinfiltrationanddenovodonorspecificantibodiesinanovelmodelofnonadherencetoimmunosuppressivetherapy
AT petraruemmele renalallograftrejectionlymphocyteinfiltrationanddenovodonorspecificantibodiesinanovelmodelofnonadherencetoimmunosuppressivetherapy
AT bernhardbanas renalallograftrejectionlymphocyteinfiltrationanddenovodonorspecificantibodiesinanovelmodelofnonadherencetoimmunosuppressivetherapy
AT tobiasbergler renalallograftrejectionlymphocyteinfiltrationanddenovodonorspecificantibodiesinanovelmodelofnonadherencetoimmunosuppressivetherapy